Fellow Publications
Selection of Fellow Publications
Phillips KA, Kamson DO, Schiff D. Disease Assessments in Patients with Glioma. Current Oncology Reports. 2023 Jul 20. doi: 10.1007/s11912-023-01440-2.
Yogendran L, Rudolf M, Yeannakis D, Fuchs K, Schiff D. Navigating disability insurance in the American healthcare system for the low-grade glioma patient. Neuro-Oncology Practice. 2023;10(1):5-12. doi: 10.1093/nop/npac076. PubMed PMID: WOS:000865997700001.
Fadul CE, Sarai G, Bovi JA, Thomas AA, Novicoff W, Anderson R, Amidon RF, Schuetz S, Singh R, Chang A, Gentzler RD, Gaughan EM, Sheehan JP. Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases. Cancers (Basel). 2023;15(12). Epub 2023/06/28. doi: 10.3390/cancers15123255. PubMed PMID: 37370865; PMCID: PMC10297002.
Yogendran LV., Ernstoff MS. Fadul CE. “Neurologic complications associated to genitourinary cancers.” Neurological Complications of Systemic Cancer and Antineoplastic Therapy, Second Edition . Newton HB., and Malkin MG. (Eds.) Netherlands: Elsevier, 3/1/2022
Yogendran L, Kalelioglu T, Donahue J, Ahmed H, Phillips K, Calautti N, Lopes MB, Asthagiri A, Purow B, Schiff D, Patel S, Fadul C. The Landscape of Brain Tumor Mimics in Neuro-Oncology Practice. Neuro-oncology. 2022;24:190-. PubMed PMID: WOS:000888571001046
Jo J, Schiff D. Current Considerations in the Treatment of Grade 3 Gliomas. Curr Treat Options Oncol 2022;23:1219-32.
Jo J, Donahue J, Sarai G, Petroni G, Schiff D. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk? Neuro Oncol 2022;24:455-64.
Phillips K, Schiff D. Epidural Metastasis and Spinal Cord Compression In: Newton HR, Malkin M (eds): Neurological Complications of Systemic Cancer and Antineoplastic Therapy, Second Edition, Academic Press, London, 2022:115-131.
Jo J, van den Bent MJ, Nabors B, Wen PY, Schiff D. Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomas. Neuro Oncol 2022;24:1035-47.
Jo J, Donahue J, Sarai G, Petroni G, Schiff D. Management of Venous Thromboembolism in High-Grade Glioma: Does Low Molecular Weight Heparin Increase Intracranial Bleeding Risk? Neuro Oncol. 2021.
Mauldin IS., Jo J., Wages NA., Yogendran LV., Mahmutovic A., Young SJ., Erickson LD., Lopes MBS., Slingluff CL., Fadul CE., “Proliferating CD8+ T cell infiltrates are associated with improved survival in glioblastoma.” Cells, 2021.
Jo J, Nevel K, Sutyla R, Smolkin M, Lopes MB, Schiff D. Predictors of early, recurrent, and intractable seizures in low-grade glioma. Neurooncol Pract 2021;8:40-7.
Phillips KA, Schiff D. Neurologic complications of transplantation. In Maziarz R, Slater S (ed.) Blood and Bone Marrow Transplant Handbook, 3rd edition. Springer, Heidelberg, 2021:593-622.
Diaz M, Jo J, Smolkin M, Ratcliffe SJ, Schiff D. Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype. Neurology 2021;96:e1063-e9.
Schiff D, Alyahya M. Neurological and Medical Complications in Brain Tumor Patients. Curr Neurol Neurosci Rep 2020;20:33.
Diaz M, Jo J, Smolkin M, Jane Ratcliffe S, Schiff D. Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype. Neurology. 2020.
Jo J, Nevel K, Sutyla R, Smolkin M, Lopes MB, Schiff D. Predictors of early, recurrent, and intractable seizures in low-grade glioma. Neuro-Oncology Practice. 2020.
Ahmad H, Jo J, Gaughan E, Fadul CE. Neurologic Toxicities from Immunotherapy. Chapter 10 in SITC’s Guide to Managing Immunotherapy Toxicity. Part II – Specific immune checkpoint inhibitor toxicities. 2019, pp 133-158
Ahmad H, Fadul CE, Schiff D, Purow B. Checkpoint inhibitor failure in hypermutated and mismatch repair-mutated recurrent high-grade gliomas. Neurooncol Pract. 2019;6(6):424-7.
Ahmad H, Martin D, Patel SH, Donahue J, Lopes B, Purow B, et al. Oligodendroglioma confers higher risk of radiation necrosis. J Neurooncol. 2019;145(2):309-19.
Phillips KA, Schiff D. Basic Principles of Brain Tumor Chemotherapy. In: Paleologos NA, Newton HB (eds). Oligodendroglioma: Clinical Presentation, Pathology, Molecular Biology, Imaging, and Treatment. Elsevier, London, 2019: 309-330.
Ahmad H, Schiff D. Multimodality Therapy of Patients with Refractory Meningiomas. Curr Treat Options Oncol. 2019;20(6):50.
Phillips KA, Fadul CE, Schiff D. Neurologic and Medical Management of Brain Tumors. Neurol Clin. 2018;36(3):449-66.
Zukas AM, Schiff D. Neurological complications of new chemotherapy agents. Neuro Oncol. 2018;20(1):24-36.
Phillips KA, Gaughan E, Gru A, Schiff D. Regression of an intramedullary spinal cord metastasis with a checkpoint inhibitor: a case report. CNS Oncol. 2017;6(4):275-80.
Raper DM, Zukas AM, Schiff D, Asthagiri AR. Geographically Remote Cerebral Venous Sinus Thrombosis in Patients with Intracranial Tumors. World Neurosurg. 2017;98:555-62.
Jo JT, Schiff D. Management of neuro-oncologic emergencies. Handb Clin Neurol. 2017;141:715-41.
Jo J, Schiff D. Brain Metastases. Chapter 141 in Neoplastic and Paraneoplastic Disease section, Neurobiology of Disease, 2nd edition 2016: pp 1011-1022
Jo J, Schiff D. Complications of Cancer Treatment. Section 13 Chapter 105 in Merritt’s Neurology, 13th edition 2015: pp 912-917
Jo J, Williams B, Smolkin M, Wintermark M, Shaffrey ME, Lopes MB, et al. Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade glioma. J Neurooncol. 2014;120(1):155-61.
Jo J, Schiff D. Metastatic Disease and the Nervous system. Chapter 26 in Aminoff’s Neurology and General Medicine, Fifth Edition 2014: pp 539-562
Jo JT, Schiff D, Perry JR. Thrombosis in brain tumors. Semin Thromb Hemost. 2014;40(3):325-31.
Jo J, Schiff D. Management Strategies in Low Grade Glioma. Neuro-oncology Learning Portfolio on Medscape Oncology Clinical Review, Medscape Education, May 2012
Jo J, Schiff D, Purow B. Angiogenic inhibition in high-grade gliomas: past, present and future. Expert Rev Neurother. 2012;12(6):733-47.
Gaughen JR, Bourne TD, Aregawi D, Shah LM, Schiff D. Focal neuronal gigantism: a rare complication of therapeutic radiation. AJNR Am J Neuroradiol. 2009;30(10):1933-5.
Sherman JH, Aregawi DG, Lai A, Fathallah-Shaykh HM, Bierman PJ, Linsky K, et al. Optic neuropathy in patients with glioblastoma receiving bevacizumab. Neurology. 2009;73(22):1924-6.
Aregawi DG, Sherman JH, Douvas MG, Burns TM, Schiff D. Case of the month: leukemic nerve infiltration. Muscle Nerve. 2009;39(3):413-4.
Aregawi D, Lopez D, Wick M, Scheld WM, Schiff D. Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. J Neurooncol. 2009;94(3):439-43.
Aregawi DG, Sherman JH, Douvas MG, Burns TM, Schiff D. Neuroleukemiosis: case report of leukemic nerve infiltration in acute lymphoblastic leukemia. Muscle Nerve. 2008;38(3):1196-200.
Cavaliere R, Wen PY, Schiff D. Novel therapies for malignant gliomas. Neurol Clin. 2007;25(4):1141-71.
Cavaliere R, Schiff D. Chemotherapy and cerebral metastases: misperception or reality? Neurosurg Focus. 2007;22(3):E6.
Cavaliere R, Farace E, Schiff D. Clinical implications of status epilepticus in patients with neoplasms. Arch Neurol. 2006;63(12):1746-9.
Cavaliere R, Schiff D. Neurologic toxicities of cancer therapies. Curr Neurol Neurosci Rep. 2006;6(3):218-26.
Cavaliere R, Schiff D. Cerebral metastases–a therapeutic update. Nat Clin Pract Neurol. 2006;2(8):426-36.
Cavaliere R, Lopes MB, Schiff D. Low-grade gliomas: an update on pathology and therapy. Lancet Neurol. 2005;4(11):760-70.
Cavaliere R, Schiff D. Fatal pulmonary embolism despite an inferior vena cava filter in glioblastoma multiforme. Neurocrit Care. 2005;3(3):249-50.
Cavaliere R, Schiff D. Epidural Spinal Cord Compression. Curr Treat Options Neurol. 2004;6(4):285-95.